Pharmocann Global Balans Gezondheid
Financiële gezondheid criteriumcontroles 3/6
Pharmocann Global has a total shareholder equity of ₪223.0K and total debt of ₪0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₪2.2M and ₪2.0M respectively.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
₪0
Schuld
| Rente dekkingsratio | n/a |
| Contant | ₪612.00k |
| Aandelen | ₪223.00k |
| Totaal verplichtingen | ₪1.95m |
| Totaal activa | ₪2.18m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence
Mar 30
Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?
Feb 04Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 31
The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come
Nov 26Analyse van de financiële positie
Kortlopende schulden: PMCN-M's short term assets (₪1.1M) do not cover its short term liabilities (₪1.8M).
Langlopende schulden: PMCN-M's short term assets (₪1.1M) exceed its long term liabilities (₪151.0K).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: PMCN-M is debt free.
Schuld verminderen: PMCN-M has no debt compared to 5 years ago when its debt to equity ratio was 0.7%.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: PMCN-M has less than a year of cash runway based on its current free cash flow.
Voorspelling contante baan: PMCN-M has less than a year of cash runway if free cash flow continues to reduce at historical rates of 34.9% each year